Acadia Pharmaceuticals Inc (ACAD)
SG&A Expense Growth
-6.30%
Quarterly · Period ending:
ACAD SG&A Expense Growth
Latest reported-6.30%period ending
Latest reported-6.30%period ending
ACAD Quarterly SG&A Growth (QoQ) (0.00% → -6.30%)
Latest values, visible window
High-resolution chart · PNG
ACAD sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -6.2958% | |
| 9.8981% | |
| 16.6528% | |
| -0.0794% | |
| 5.6477% | |
| -2.8521% | |
| -2.4112% | |
| 13.8652% | |
| 8.4007% | |
| -3.1167% | |
| 13.8676% | |
| 2.0028% | |
| -5.2027% | |
| -3.0335% | |
| 33.6636% | |
| -13.1178% | |
| -7.0108% | |
| -8.7176% | |
| 29.6892% | |
| -15.6247% | |
| -13.3189% | |
| -7.5287% | |
| 47.9949% | |
| -3.2628% | |
| -17.2879% | |
| 10.9959% | |
| 26.377% | |
| 6.9358% | |
| -26.9728% | |
| 25.3383% | |
| 21.5784% | |
| -12.0667% | |
| 14.0269% | |
| -8.6416% | |
| 7.1223% | |
| 1.1898% | |
| -6.4218% | |
| 14.0159% | |
| 14.1073% | |
| -0.4609% | |
| 84.6713% | |
| 9.4561% | |
| 23.6754% | |
| -3.8401% | |
| -12.9508% | |
| 132.8311% | |
| 29.3285% | |
| 1.3204% | |
| 25.8228% | |
| 47.8017% | |
| 12.6152% | |
| 52.1234% | |
| 16.0391% | |
| -6.3969% | |
| 54.7475% | |
| -4.563% | |
| -6.2651% | |
| 12.3139% | |
| -2.6991% | |
| -44.3386% | |
| 44.8514% | |
| 24.1107% | |
| -3.8023% | |
| 1.6753% | |
| -14.4432% | |
| -31.2618% | |
| 32.347% | |
| -25.0939% | |
| -10.9103% | |
| 25.0209% | |
| -19.6369% | |
| -6.5955% | |
| -2.63% | |
| 8.6379% | |
| 2.3461% | |
| -7.0187% | |
| 0.349% | |
| -28.4287% | |
| 86.2944% | |
| 2.9617% | |
| 0.5254% | |
| -74.3359% | |
| 247.627% | |
| 4.699% | |
| 21.6638% | |
| -7.1214% | |
| 9.2548% | |
| 32.5348% | |
| -6.9837% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |